查詢結果分析
來源資料
相關文獻
- The Role of Radiotherapy for Advanced Non-Small Cell Lung Cancer
- 成人低惡性度顱內星狀細胞瘤之術後放射治療
- Fractionated Stereotactic Radiotherapy for Malignant Glioma
- Treatment Results of Malignant Lymphoma of Nasopharynx at National Taiwan University Hospital
- Treatment Results of Hodgkin's Disease from 1977 to 1991 in National Taiwan University Hospital
- Treatment Results of Laryngeal Cancer by Radiotherapy with or Without Surgery
- 中晚期子宮頸癌放射線合併化學治療之近況
- Computational Evaluation of Biological Effects of Dimthylsulphoxide for Radiotherapy
- Comparison of Weekly Vinorelbine and Weekly Docetaxel, Each with Cisplatin, for Locally Advanced Non-small Cell Lung Cancer in Patients with Concurrent Chemoradiotherapy
- Conserving Surgical Treatment Plus Radiotherapy for Breast Cancer
頁籤選單縮合
題 名 | The Role of Radiotherapy for Advanced Non-Small Cell Lung Cancer=胸腔放射治療無法提昇晚期非小細胞肺癌之存活率 |
---|---|
作 者 | 邱世哲; 張國華; 陳裕仁; 鍾昌宏; 賴允亮; 吳孟浩; | 書刊名 | 放射治療與腫瘤學 |
卷 期 | 5:4 1998.12[民87.12] |
頁 次 | 頁277-283 |
分類號 | 416.224、416.224 |
關鍵詞 | 存活率; 放射治療; 晚期非小細胞肺癌; Survival; Radiotherapy; Advanced non-small cell lung cancer; |
語 文 | 英文(English) |
中文摘要 | 目的:評估放射治療對於晚期非小細胞肺癌病人之適當性。 材料與方法:共有 89 名病患於 1992 年 7 月至 1997 年 6 月間到馬偕紀念醫院求診。其 中 63 位曾接受放射治療,另外 23 位則否。對於第三期之病患將給予胸腔放射治療,而第 四期之病患則只針對轉移部位或引起之症狀給予放射治療。結果:相對於沒有接受放射治療 的病人比較起來,晚期非小細胞肺癌病人接受放射治療並沒有存活率增加之優點。結論:胸 腔放射治療並不能增加晚期非小細胞肺癌病人之存活率。 |
英文摘要 | Purpose:To re-evaluate the appropriateness of thoracic radiotherapy (RT) for patients with advanced non-small cell lung cancer (NSCLC). Materials and Methods:This retrospective study included 89 patients with advanced NSCLC registered in Mackay Memorial Hospital from July 1992 to June 1997. Thoracic RT was given with radical or palliative intent depending on the stage and/or performance status at diagnosis to 63 (the RT group) but had withheld in 26 (the non-RT group). The total dose to the primary tumor was in the range of 5000-6000 cGy at 180 cGy per fraction over 5-6.5 weeks. Tumor control was strictly defined as complete disappearance of tumor on all radiographic examinations and/or no evidence of disease clinically at the last follow up. Results:No survival advantage was noted in the RT group compared to the non-RT group (median 3.0 vs. 5.5 months). The mean survival time of patients with stage Ⅲ disease was 11.37 ± 1.94 months and median survival time was 8 months. The control rate in the RT group was poor with only 4 of 63 (6%) disease-free on the last follow up. One of four patients who were disease-free died of radiation pneumonitis about 3 months after complete of RT. In addition, one patient with stage lllb was still alive, undergoing chemotherapy for distant metastasis. Conclusion:Thoracic RT did not prolong survival for patients with locally advanced NSCLC. |
本系統中英文摘要資訊取自各篇刊載內容。